TLR4 and cancer: In addition, NETs can also release NE and activate the TLR4-p38-PGC-1α axis in cancer cells to increase mitochondrial biosynthesis, endowing cancer cells with survival advantages that leads to their migration and invasion and subsequent establishment of clinically difficult-to-detect micrometastatic disease, ultimately leading to tumor recurrence [188].